Neoadjuvant chemotherapy with docetaxel-cisplatin in patients with stage III N2 non-small-cell lung cancer

Clinical Lung Cancer

Volumn 14, Issue 4, 2013, Pages 418-424

  Liao, Wei Yu ^a   Chen, Jin Hsin ^a   Wu, Muzo ^a   Shih, Jin Yuan ^a   Chen, Kuan Yuh ^a   Ho, Chao Chi ^a   Yang, James Chih Hsin ^b   Yu, Chong Jen ^a  

^a NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^b NATIONAL TAIWAN UNIVERSITY   (Taiwan)

Author keywords

Cisplatin; Docetaxel; Neoadjuvant chemotherapy; Non small cell lung cancer

Indexed keywords

CISPLATIN; DOCETAXEL; UFT;

ADULT; AGED; ALOPECIA; ANEMIA; ARTICLE; CANCER ADJUVANT THERAPY; CANCER COMBINATION CHEMOTHERAPY; CANCER PROGNOSIS; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER SURGERY; DIARRHEA; DISEASE SEVERITY; DRUG EFFICACY; EVENT FREE SURVIVAL; FATIGUE; FEMALE; FOLLOW UP; HISTOPATHOLOGY; HUMAN; LEUKOPENIA; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; NAIL DISEASE; NAUSEA; OUTCOME ASSESSMENT; OVERALL SURVIVAL; RETROSPECTIVE STUDY; SQUAMOUS CELL CARCINOMA; SURVIVAL RATE; TREATMENT RESPONSE; VOMITING;

ADENOCARCINOMA; ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOMA, NON-SMALL-CELL LUNG; CARCINOMA, SQUAMOUS CELL; CHEMOTHERAPY, ADJUVANT; CISPLATIN; FEMALE; FOLLOW-UP STUDIES; HUMANS; LUNG NEOPLASMS; LYMPHATIC METASTASIS; MALE; MEDIASTINUM; MIDDLE AGED; NEOADJUVANT THERAPY; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; PROGNOSIS; RETROSPECTIVE STUDIES; SURVIVAL RATE; TAXOIDS;

EID: 84878774286     PISSN: 15257304     EISSN: 19380690     Source Type: Journal    
DOI: 10.1016/j.cllc.2012.10.003     Document Type: Article

References (34)

1. G.A. Silvestri, J. Jett Bronchogenic carcinoma R.J. Mason, V.C. Broaddus, J.F. Murray, Murray and Nadel's Textbook of Respiratory Medicine 2005 Elsevier Saunders Philadelphia 1371
2. P. Yang, M.S. Allen, M.C. Aubry Clinical features of 5,628 primary lung cancer patients: experience at Mayo Clinic from 1997 to 2003 Chest 128 2005 452 462
3. B.B. Park, J.O. Park, H. Kim Is trimodality approach better than bimodality in stage IIIA, N2 positive non-small cell lung cancer? Lung Cancer 53 2006 323 330
4. T. Naruke, T. Goya, R. Tsuchiya The importance of surgery to non-small cell carcinoma of lung with mediastinal lymph node metastasis Ann Thorac Surg 46 1988 603 611
5. F.G. Pearson, N.C. DeLarure, R. Ilves Significance of positive superior mediastinal nodes identified at mediastinoscopy in patients with respectable cancer of the lung J Thorac Cardiovasc Surg 83 1982 1 11
6. T.W. Shields The significance of ipsilateral mediastinal lymph node metastasis (N2 disease) in non-small cell carcinoma of the lung: a commentary J Thorac Cardiovasc Surg 99 1990 48 53
7. R.B. Livingston Combined modality therapy of lung cancer Clin Cancer Res 3 1997 2638 2647
8. P. Kumar, J. Herndon II, M. Langer Patterns of disease failure after trimodality therapy of nonsmall cell lung carcinoma pathologic stage IIIA (N2): analysis of cancer and Leukemia Group B protocol 8935 Cancer 77 1996 2393 2399
9. D.J. Sugarbaker, J. Herndon, L.J. Kohman Results of Cancer and Leukemia Group B protocol 8935: a multiinstitutional phase II trimodality trial for stage IIA (N2) non-small-cell lung cancer J Thorac Cardiovasc Surg 109 1995 473 485
10. J.A. Roth, E.N. Atkinson, F. Fossella Long-term follow-up of patients enrolled in a randomized trial comparing perioperative chemotherapy and surgery with surgery alone in resectable stage IIIA non-small-cell lung cancer Lung Cancer 21 1998 1 6
11. R. Rosell, J. Gómez-Codina, C. Camps Preresectional chemotherapy in stage IIIA non-small-cell lung cancer: a 7-year assessment of a randomized controlled trial Lung Cancer 26 1999 7 14
12. N. Martini, M.G. Kris, B.J. Flehinger Preoperative chemotherapy for stage IIIa (N2) lung cancer: the Sloan-Kettering experience with 136 patients Ann Thorac Surg 55 1993 1365 1373
13. W.A. Song, N.K. Zhou, W. Wang Survival benefit of neoadjuvant chemotherapy in non-small cell lung cancer: an updated meta-analysis of 13 randomized control trials J Thorac Oncol 5 2010 510 516
14. D.C. Betticher, S.F. Hsu Schmitz, M. Tötsch Prognostic factors affecting long-term outcomes in patients with resected stage IIIA pN2 non-small-cell lung cancer: 5-year follow-up of a phase II study Br J Cancer 94 2006 1099 1106
15. A. Depierre, B. Milleron, D. Moro-Sibilot Preoperative chemotherapy followed by surgery compared with primary surgery in resectable stage I (except T1N0), II, and IIIa non-small-cell lung cancer J Clin Oncol 20 2002 247 253
16. D.C. Betticher, S.F. Hsu Schmitz, M. Tötsch Mediastinal lymph node clearance after docetaxel-cisplatin neoadjuvant chemotherapy is prognostic of survival in patients with stage IIIA pN2 non-small-cell lung cancer: a multicenter phase II trial J Clin Oncol 21 2003 1752 1759
17. T.L. Le Chevalier, J. Bérille, J.R. Zalcberg Overview of docetaxel (Taxotere)/cisplatin combination in non-small cell lung cancer Semin Oncol 26 suppl 11 1999 13 18
18. Y. Ohe, S. Niho, R. Kakinuma Phase I studies of cisplatin and docetaxel administered by three consecutive weekly infusions for advanced non-small cell lung cancer in elderly and non-elderly patients Jpn J Clin Oncol 31 2001 100 106
19. J.H. Schiller, D. Harrington, C.P. Belani Comparison of four chemotherapy regimens for advanced non-small-cell lung cancer N Engl J Med 346 2002 92 98
20. K. Kubota, K. Watanabe, H. Kunitoh Phase III randomized trial of docetaxel plus cisplatin versus vindesine plus cisplatin in patients with stage IV non-small-cell lung cancer: the Japanese Taxotere Lung Cancer Study Group J Clin Oncol 22 2004 254 261
21. F. Fossella, J.R. Pereira, J. von Pawel Randomized, multinational, phase III study of docetaxel plus platinum combinations versus vinorelbine plus cisplatin for advanced non-small-cell lung cancer: the TAX 326 study group J Clin Oncol 21 2003 3016 3024
22. Y.M. Chen, R.P. Perng, J.F. Shih A randomized phase II study of docetaxel or vinorelbine in combination with cisplatin against inoperable, chemonaive non-small-cell lung cancer in Taiwan Lung Cancer 56 2007 363 369
23. D.C. Betticher, R. Rosell Neoadjuvant treatment of early-stage resectable non-small-cell lung cancer Lung Cancer 46 suppl 2 2004 S23 S32
24. P.P. Brega Massone, B. Conti, B. Magnani Video-assisted thoracoscopic surgery for diagnosis, staging, and management of lung cancer with suspected mediastinal lymphadenopathy Surg Laparosc Endosc Percutan Tech 12 2002 104 109
25. M. Di Maio, F. Perrone, P. Chiodini Individual patient data meta-analysis of docetaxel administered once every 3 weeks compared with once every week second-line treatment of advanced non-small-cell lung cancer J Clin Oncol 25 2007 1377 1382
26. T.G. Clark, M.J. Bradburn, S.B. Love Survival analysis part I: basic concepts and first analyses Br J Cancer 89 2003 232 238
27. T. Berghmans, M. Paesmans, A.P. Meert Survival improvement in resectable non-small cell lung cancer with (neo)adjuvant chemotherapy: results of a meta-analysis of the literature Lung Cancer 49 2005 12 23
28. B. Biesma, C. Manegold, H.J. Smit Docetaxel and cisplatin as induction chemotherapy in patients with pathologically proven stage IIIA N2 non-small cell lung cancer: a phase II study of the European Organization for Research and Treatment of Cancer (EORTC 08984) Eur J Cancer 42 2006 1399 1406
29. K.S. Albain, V.W. Rusch, J.J. Crowley Concurrent cisplatin/etoposide plus chest radiotherapy followed by surgery for stages IIIA (N2) and IIIB non-small-cell lung cancer: mature results of Southwest Oncology Group phase II study 8805 J Clin Oncol 13 1995 1880 1892
30. A.D. Elias, A.T. Skarin, T. Leong Neoadjuvant therapy for surgically staged IIIA N2 non-small cell lung cancer Lung Cancer 17 1997 147 161
31. R.L. Burkes, F.A. Shepherd, M.E. Blackstein Induction chemotherapy with mitomycin, vindesine, and cisplatin for stage IIIA (T1-3, N2) unresectable non-small-cell lung cancer: final results of the Toronto Phase II Trial Lung Cancer 47 2005 103 109
32. B. Milleron, V. Westeel, E. Quoix Complete response following preoperative chemotherapy for resectable non-small cell lung cancer: accuracy of clinical assessment using the French Trial database Chest 128 2005 1442 1447
33. F.R. Hirsch, A. Spreafico, S. Novello The prognostic and predictive role of histology in advanced non-small cell lung cancer: a literature review J Thorac Oncol 3 2008 1468 1481
34. G. Mouillet, E. Monnet, B. Milleron Pathologic complete response to preoperative chemotherapy predicts cure in early-stage non-small-cell lung cancer: combined analysis of two IFCT randomized trials J Thorac Oncol 7 2012 841 849